BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38820867)

  • 21. Three-dimensional Monte Carlo-based voxel-wise tumor dosimetry in patients with neuroendocrine tumors who underwent
    Goetz TI; Lang EW; Prante O; Maier A; Cordes M; Kuwert T; Ritt P; Schmidkonz C
    Ann Nucl Med; 2020 Apr; 34(4):244-253. PubMed ID: 32114682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Pipeline for Automated Voxel Dosimetry: Application in Patients with Multi-SPECT/CT Imaging After
    Dewaraja YK; Mirando DM; Peterson AB; Niedbala J; Millet JD; Mikell JK; Frey KA; Wong KK; Wilderman SJ; Nelson AS
    J Nucl Med; 2022 Nov; 63(11):1665-1672. PubMed ID: 35422445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetry of
    Violet J; Jackson P; Ferdinandus J; Sandhu S; Akhurst T; Iravani A; Kong G; Kumar AR; Thang SP; Eu P; Scalzo M; Murphy D; Williams S; Hicks RJ; Hofman MS
    J Nucl Med; 2019 Apr; 60(4):517-523. PubMed ID: 30291192
    [No Abstract]   [Full Text] [Related]  

  • 24. Lesion Dosimetry for [
    Grkovski M; O'Donoghue JA; Imber BS; Andl G; Tu C; Lafontaine D; Schwartz J; Thor M; Zelefsky MJ; Humm JL; Bodei L
    J Nucl Med; 2023 Nov; 64(11):1779-1787. PubMed ID: 37652541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MIRD Pamphlet No. 26: Joint EANM/MIRD Guidelines for Quantitative 177Lu SPECT Applied for Dosimetry of Radiopharmaceutical Therapy.
    Ljungberg M; Celler A; Konijnenberg MW; Eckerman KF; Dewaraja YK; Sjögreen-Gleisner K; ; Bolch WE; Brill AB; Fahey F; Fisher DR; Hobbs R; Howell RW; Meredith RF; Sgouros G; Zanzonico P; ; Bacher K; Chiesa C; Flux G; Lassmann M; Strigari L; Walrand S
    J Nucl Med; 2016 Jan; 57(1):151-62. PubMed ID: 26471692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biodistribution and dosimetry of a single dose of albumin-binding ligand [
    Kramer V; Fernández R; Lehnert W; Jiménez-Franco LD; Soza-Ried C; Eppard E; Ceballos M; Meckel M; Benešová M; Umbricht CA; Kluge A; Schibli R; Zhernosekov K; Amaral H; Müller C
    Eur J Nucl Med Mol Imaging; 2021 Mar; 48(3):893-903. PubMed ID: 32949253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation Dosimetry in
    Jackson P; Hofman M; McIntosh L; Buteau JP; Ravi Kumar A
    Semin Nucl Med; 2022 Mar; 52(2):243-254. PubMed ID: 34893320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [
    Arbuznikova D; Klotsotyra A; Uhlmann L; Domogalla LC; Steinacker N; Mix M; Niedermann G; Spohn SKB; Freitag MT; Grosu AL; Meyer PT; Gratzke C; Eder M; Zamboglou C; Eder AC
    Theranostics; 2024; 14(6):2560-2572. PubMed ID: 38646643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual-Time-Point Posttherapy
    Straub M; Kupferschläger J; Serna Higuita LM; Weissinger M; Dittmann H; la Fougère C; Fiz F
    J Nucl Med; 2023 Sep; 64(9):1431-1438. PubMed ID: 37414446
    [No Abstract]   [Full Text] [Related]  

  • 30. Pretherapeutic 68Ga-PSMA-617 PET May Indicate the Dosimetry of 177Lu-PSMA-617 and 177Lu-EB-PSMA-617 in Main Organs and Tumor Lesions.
    Wang J; Zang J; Wang H; Liu Q; Li F; Lin Y; Huo L; Jacobson O; Niu G; Fan X; Zhu Z; Chen X
    Clin Nucl Med; 2019 Jun; 44(6):431-438. PubMed ID: 30985422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.
    Gosewisch A; Ilhan H; Tattenberg S; Mairani A; Parodi K; Brosch J; Kaiser L; Gildehaus FJ; Todica A; Ziegler S; Bartenstein P; Böning G
    EJNMMI Res; 2019 Aug; 9(1):76. PubMed ID: 31414241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric Analysis of a Phase I Study of PSMA-Targeting Radiopharmaceutical Therapy With [
    Ha S; O JH; Park C; Boo SH; Yoo IR; Moon HW; Chi DY; Lee JY
    Korean J Radiol; 2024 Feb; 25(2):179-188. PubMed ID: 38288897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The
    Scarpa L; Buxbaum S; Kendler D; Fink K; Bektic J; Gruber L; Decristoforo C; Uprimny C; Lukas P; Horninger W; Virgolini I
    Eur J Nucl Med Mol Imaging; 2017 May; 44(5):788-800. PubMed ID: 28083690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal and Multiorgan Safety of
    Herrmann K; Rahbar K; Eiber M; Sparks R; Baca N; Krause BJ; Lassmann M; Jentzen W; Tang J; Chicco D; Klein P; Blumenstein L; Basque JR; Kurth J
    J Nucl Med; 2024 Jan; 65(1):71-78. PubMed ID: 38050121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kidney Doses in
    Mix M; Renaud T; Kind F; Nemer U; Yousetzadeh-Nowsha E; Moalosi TCG; Ormrane AM; Meyer PT; Ruf J
    J Nucl Med; 2022 Feb; 63(2):253-258. PubMed ID: 34088773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation Dosimetry for
    Okamoto S; Thieme A; Allmann J; D'Alessandria C; Maurer T; Retz M; Tauber R; Heck MM; Wester HJ; Tamaki N; Fendler WP; Herrmann K; Pfob CH; Scheidhauer K; Schwaiger M; Ziegler S; Eiber M
    J Nucl Med; 2017 Mar; 58(3):445-450. PubMed ID: 27660138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodistribution and dosimetry for combined [
    Delker A; Schleske M; Liubchenko G; Berg I; Zacherl MJ; Brendel M; Gildehaus FJ; Rumiantcev M; Resch S; Hürkamp K; Wenter V; Unterrainer LM; Bartenstein P; Ziegler SI; Beyer L; Böning G
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1280-1290. PubMed ID: 36629878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging expression of prostate-specific membrane antigen and response to PSMA-targeted β-emitting radionuclide therapies in metastatic castration-resistant prostate cancer.
    Vlachostergios PJ; Niaz MJ; Skafida M; Mosallaie SA; Thomas C; Christos PJ; Osborne JR; Molina AM; Nanus DM; Bander NH; Tagawa ST
    Prostate; 2021 Apr; 81(5):279-285. PubMed ID: 33465252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy.
    Widjaja L; Werner RA; Krischke E; Christiansen H; Bengel FM; Bogdanova N; Derlin T
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):602-612. PubMed ID: 36136101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy.
    Garkavij M; Nickel M; Sjögreen-Gleisner K; Ljungberg M; Ohlsson T; Wingårdh K; Strand SE; Tennvall J
    Cancer; 2010 Feb; 116(4 Suppl):1084-92. PubMed ID: 20127957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.